Comparing the current results to its competitors, Aurora Cannabis Inc reported Revenue increase in the 4 quarter 2026 by 0 % year on year. The revenue growth was below Aurora Cannabis Inc 's competitors' average revenue growth of 1250.06 %, achieved in the same quarter.
Aurora Cannabis Inc 's Comment on Competition and Industry Peers
Aurora aims to enhance its competitive position through improved flower supply management and international expansion, utilizing its capabilities in regulatory navigation, compliance, testing, cultivar breeding, genetic science, and cultivation. The global medical and recreational cannabis markets are growing, with ongoing regulatory developments in the U.S. and increased exports from Canada. Aurora holds a leading market share despite a competitive and contracting market, notably in Australia where multiple new product launches and lower prices are common. To expand access to patients and physicians, Aurora established a distribution partnership with Leafio, the wholesale distribution division of Montu Australia, to distribute its medical cannabis products under brands including MedReleaf, CraftPlant, Aurora, Whistler Cannabis Co., and IndiMed.
Kaya Holdings Inc's business model revolves around operating and franchising legal cannabis retail stores under the Smoke Shop brand. Their focus is on offering a diverse range of cannabis products, accessories, and services to cater to the needs of consumers in states where marijuana is legalized.
Fsd Pharma Inc's business model is centered around the development and production of pharmaceutical-grade cannabis products. The company aims to leverage its in-house cultivation facility, research and development capabilities, and strategic partnerships to create innovative cannabis-based therapies for various medical conditions. Fsd Pharma focuses on pursuing licensing and acquisition opportunities to expand its presence in the global cannabis market.
Igc Pharma Inc's business model revolves around the development and commercialization of innovative therapeutics derived from cannabis-based compounds. The company focuses on researching treatments for indications such as epilepsy, pain, and inflammation. Igc Pharma Inc primarily operates in the pharmaceutical industry, aiming to provide safe and effective alternatives to conventional medicines.
Intercure Ltd is a company that operates in the healthcare sector. Their business model focuses on providing innovative medical solutions and technologies to improve patient outcomes and quality of life. They likely collaborate with healthcare providers, research institutions, and pharmaceutical companies to develop and market their products.
Sources:
Aurora Cannabis Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Aurora Cannabis Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
